(Press-News.org) New Haven, Conn. — Cancer fighting T-cells, the immune system’s primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell carcinoma (ChRCC) and those that are present are indifferent to the tumor threat and traditional immune therapies, revealing the need for new targets and treatments.
Those are among the results described in a July 2 published report in the Journal of Clinical Oncology that set out to understand the biology of certain kidney tumors, including ChRCC, and their immune responses.
The study found that ChRCC, which accounts for about 5 percent of all kidney cancers, has fewer T-cells and key molecules required for an immune response than other kidney cancers and poorer response and survival rates when treated with immune-based therapies. Other examined kidney tumors included in the study were Low-grade oncocytic tumor (LOT) and the usually benign renal oncocytoma (RO).
“Chromophobe renal cell carcinoma remains a major challenge to treat in the clinic, in large part because we do not have a deep understanding of the underlying biology. Most of the available treatments were developed for other types of kidney cancer, and do not take into account the unique immune features of this rarer cancer type,” said Yale Cancer Center’s David Braun, MD, PhD, corresponding author of the study.
This study was co-led by other senior others Elizabeth P. Henske, MD of Brigham and Women’s Hospital in Boston, Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, Eliezer M. Van Allen, MD, of Dana-Farber Cancer Institute, and Sachet Shukla, PhD, of MD Anderson Cancer Center. The first author of the study was Chris Labaki, MD, now at the Beth Israel Deaconess Medical Center. It also included several dozen researchers from institutions in the US and Canada.
The study’s detailed machine learning analysis of individual cells from ChRCC tumors, as well as normal tissue, helped determine the origin of the tumor from a specific type of kidney cell, α-intercalated cells. Researchers identified genes activated or deactivated in ChRCC tumors compared to the original normal cell. The study further used single-cell sequencing analysis of immune cells in the tumor to learn how ChRCC cancer cells actively hide from the immune system.
“For many more common types of kidney cancer, that are many immune cells that are present and capable of recognizing the tumor cells, but lack their normal function because they are ‘exhausted.’ Conventional immune checkpoint inhibition makes sense for those kidney cancers. For ChRCC, however, the mechanism of immune evasion is completely different. We therefore need therapeutic strategies that steer cancer-specific immune cells into the tumor,” said Braun, a researcher in YCC’s Center of Molecular and Cellular Oncology and assistant professor of medicine, pathology, and urology at Yale School of Medicine.
While providing new understanding of ChRCC and treatment pathways that could be explored, the study noted limitations, including sample size and the need for further research.
Funding for this work includes the U.S. Department of Defense (award W81XWH-19-1-0550), the US DOD Early Career Investigator Grant (KCRP AKCIECI, W81XWH-20-1-0882), the Kidney Cancer Association (KCA) Trailblazer Award, the Louis Goodman and Alfred Gilman Yale Scholar Fund, the National Institutes of Health, National Cancer Institute (1R37CA279822-01), and the Yale Cancer Center (supported by NIH/NCI research grant P30CA016359). This project was supported in part by a KCRP award the Tuttle Family, and Yale University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
######
END
Novel insights into chromophobe renal cell carcinoma biology and potential therapeutic strategies
2025-07-03
ELSE PRESS RELEASES FROM THIS DATE:
A breakthrough in motor safety: AI-powered warning system enhances capability to uncover hidden winding faults
2025-07-03
Enhanced diagnostic method of the ITSC fault
The study, led by Dr. Wentao Huang, overcame a critical gap in five-phase permanent magnet synchronous motor (PMSM) diagnostics: conventional methods fail to assess inter-turn short-circuit (ITSC) severity. The method integrates two technologies: a real-time tracker that diagnoses faults, and an AI analyzer that processes signals to quantify damage while estimating short-circuit parameters.
Overcoming the Blind Spot
For years, the challenge of quantifying inter-turn short-circuit severity in operating motors has stumped engineers, as traditional methods struggled ...
Research teases apart competing transcription organization models
2025-07-03
Scientists at St. Jude Children’s Research Hospital have reconciled two closely related but contentious mechanisms underlying transcription, the process of converting genetic information in DNA into messenger RNA. Phase separation has been proposed as a driving force in transcription due to its ability to selectively concentrate proteins and DNA in discrete droplets. However, scientists have been unclear about what really matters for transcription: the phase-separated droplets or the molecular interactions that contribute to phase separation by forming networks.
To address ...
Connect or reject: Extensive rewiring builds binocular vision in the brain
2025-07-03
Scientists have long known that the brain’s visual system isn’t fully hardwired from the start—it becomes refined by what babies see—but the authors of a new MIT study still weren’t prepared for the degree of rewiring they observed when they took a first-ever look at the process in mice as it happened in real-time.
As the researchers in The Picower Institute for Learning and Memory tracked hundreds of “spine” structures housing individual network connections, or “synapses,” on the dendrite branches of neurons in the visual cortex over 10 days, they saw that only 40 percent of the ...
Benefits and risks: informal use of antibiotics to prevent sexually transmitted infections on the rise in key populations in the Netherlands
2025-07-03
New research analysing an online survey of 1,633 respondents found 15% recent use of doxycycline post- and pre-exposure prophylaxis (doxyPEP/PrEP) among men who have sex with men (MSM), transgender and gender diverse people in the Netherlands according to a recent study published by Eurosurveillance [1]. These data highlight an increase in the informal use of doxyPEP/PrEP, with 65% of the participants intending to use it in the future. Currently, doxyPEP/PrEP is not recommended or actively promoted by healthcare professionals in the Netherlands. Informal ...
New molecular tool sheds light on how cancer cells repair telomeres
2025-07-03
Each time a cell divides, a small section of each chromosome’s protective cap — the telomere — is worn away. Most cells use an enzyme called telomerase to help mitigate this loss, but 10% to 15% of cancers have another mechanism called the alternative lengthening of telomeres (ALT) pathway.
“ALT is found in some of the worst cancers, such as pancreatic neuroendocrine tumors, osteosarcomas and subsets of glioma,” said Roderick O’Sullivan, Ph.D., professor in the Department of Pharmacology and Chemical Biology at the University of Pittsburgh and UPMC Hillman Cancer Center. “Interfering with ALT in these cancers ...
First large-scale stem cell bank enables worldwide studies on genetic risk for Alzheimer’s disease
2025-07-03
Alzheimer’s disease (AD) is a common, debilitating neurodegenerative disease affecting about 10 percent of people over the age of 65 and one third of people aged 85 and above. Besides environmental factors, the genes have a strong influence on whether or not a person develops AD during their lifetime. Through genome sequencing of DNA from large groups of healthy people and people with AD, some naturally occurring small changes in the DNA, known as genetic variants, were found to be more frequent in AD patients than in healthy people. As more and more of these AD-associated genetic “risk” variants are discovered, ...
Hearing devices significantly improve social lives of those with hearing loss
2025-07-03
LOS ANGELES — Hearing loss doesn’t just affect how people hear the world — it can also change how they connect with it.
A new study from the USC Caruso Department of Otolaryngology – Head and Neck Surgery, part of Keck Medicine of USC, published today in JAMA Otolaryngology – Head & Neck Surgery, is the first to link hearing aids and cochlear implants, surgically implanted devices that help those with profound hearing loss perceive sound, to improved social lives among adults with hearing loss.
“We found that adults with hearing loss who used hearing aids or cochlear ...
CNIC scientists reveal how the cellular energy system evolved—and how this knowledge could improve the diagnosis of rare genetic diseases
2025-07-03
Mitochondria are the body’s “energy factories,” and their proper function is essential for life. Inside mitochondria, a set of complexes called the oxidative phosphorylation (OxPhos) system acts like a biochemical assembly line, transforming oxygen and nutrients into usable energy.
Now, the study, led by the GENOXPHOS group at the Spanish National Centre for Cardiovascular Research (CNIC) and the Biomedical Research Networking Centre in the area of Frailty and Healthy Ageing (CIBERFES), and directed by Dr. José Antonio Enríquez, has revealed how this system evolved ...
AI sharpens pathologists' interpretation of tissue samples
2025-07-03
Pathologists' examinations of tissue samples from skin cancer tumours improved when they were assisted by an AI tool. The assessments became more consistent and patients' prognoses were described more accurately. This is shown by a study led by Karolinska Institutet, conducted in collaboration with researchers from Yale University.
It is already known that tumour-infiltrating lymphocytes (TILs) are an important biomarker in several cancers, including malignant melanoma (skin cancer). TILs are immune cells found in or near the tumour, where they influence the body's response to the cancer. In ...
Social outcomes among adults with hearing aids and cochlear implants
2025-07-03
About The Study: In this systematic review and meta-analysis, hearing rehabilitative devices were associated with improved social outcomes for adults with hearing loss. Their use should be encouraged for those with hearing loss to potentially enhance social engagement and functional outcomes.
Corresponding Author: To contact the corresponding author, Janet S. Choi, MD, MPH, email janet.choi@med.usc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoto.2025.1777)
Editor’s Note: Please see the article for additional information, including ...